CASP9 and melanoma: A promising strategy to inhibit melanoma progression has been found for the combination of DM-1, a curcumin analog, and dacarbazine in B16F10 melanoma-bearing mice by the activation of apoptosis with the cleavage of caspase-3, caspase-8, and caspase-9 [163].